A New Endotoxin Testing Platform: Sievers Eclipse BET

A Closer Look at Efficiency Gains, Comparability, and Analytical Results

Previously Aired on July 15th, 2020

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.



In this webinar, attendees will receive an introduction to the groundbreaking Sievers Eclipse BET Platform to understand why it was created and how it works to simplify and automate endotoxin assay setup, while maintaining full compliance with USP <85>. With Eclipse, compliant 21-sample assays can be set up in as little as 9 minutes, leading to substantial efficiency gains.

This webinar will also focus on how to evaluate this revolutionary technology. From comparability of analytical results across platforms to data integrity and validation testing, this webinar will leave attendees with a solid understanding of how the Eclipse platform stacks up next to other technology on the market, and how it can be evaluated and validated in a QC lab to demonstrate viability for routine endotoxin testing.

In this webinar you’ll learn:

• Why and how the Sievers Eclipse platform was developed

• How the Eclipse platform increases efficiency and automates endotoxin testing

• How the Eclipse platform aligns with USP <85>, EP 2.6.14, and JP 4.01

• Comparability of analytical results across different platforms

• Data integrity

• Validation testing and validation tools available to customers

Who should attend:

• QA & QC personnel

• Microbiology personnel

• Validation personnel

• Metrology personnel

•Operations personnel


David Wadsworth
Global Product Manager, Bio-Detection
View Biography
Sydney Jannetta
Product Application Specialist, Life Sciences
View Biography
Mike Auerbach
American Pharmaceutical Review